EMA 2015 budget up as pharmacovigilance fees kick in; Rasi becomes 'principal adviser'
This article was originally published in SRA
At least someone has managed to secure an increase in their spending power for the coming year, despite the straitened economic times. The European Medicines Agency's budget for 2015 has been set at just over €302m, up by 7% over the 2014 figure of €282.5m1. In other EMA-related news, Guido Rasi, who stepped down as executive director of the agency last month2, has just been made principal adviser in charge of strategy and is continuing to play a key role.